Strategic Partnerships

Foundation Medicine collaborates with academic and commercial organizations that share in our vision of a transformation in cancer care driven by a deep understanding of cancer genomics.

Current pharmaceutical collaborations leverage Foundation Medicine’s comprehensive cancer genomics test in ongoing trials of drug candidates with the goal of speeding up recruitment of target patient populations and for broad genetic characterization of all trial enrollees. These collaborations may ultimately enable discovery of heretofore unappreciated genomic abnormalities and pathways in cancer which can be exploited to further improve diagnosis and therapy of the disease.